The Cll12 Trial Protocol: A Placebo-Controlled Double-Blind Phase Iii Study of Ibrutinib in the Treatment of Early-Stage Chronic Lymphocytic Leukemia Patients with Risk of Early Disease Progression
FUTURE ONCOLOGY（2015）
关键词
B-cell receptor signaling,Binet A,Bruton's tyrosine kinase,CLL,ibrutinib,wait,watch
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要